Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (5): 817-820    DOI: 10.31083/j.ejgo.2020.05.5372
Case Report Previous articles | Next articles
Uterine mullerian adenosarcoma in very young patient
Tajossadat Allameh1, *(), Elham Naghshineh1, Leila Mousavi Seresht2, Parvin Rajabi3, Narges Izadi-Mood4
1Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3Professor of pathology, Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
4Professor of pathology, Department of Pathology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Download:  PDF(5246KB)  ( 190 ) Full text   ( 14 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Introduction: Uterine adenosarcoma mostly seen in elderly and there are limited data on appropriate approach in premenopausal patient and the accurate prognosis. Herein we aimed to present a young case of Müllerian adenosarcoma of uterus which had only 9 years old. Case report: A 9year old pre pubertal girl presented to the gynecology department of Isfahan University of Medical Sciences-Iran with the vaginal bleeding. An intrauterine mass was noted via hysteroscopic examination as the reason of abnormal bleeding. The final pathology revealed Müllerian adenosarcoma of uterus. Subsequently hysterectomy was done due to persistent perfused vaginal bleeding; with ovarian preservation. Conclusion: Due to rarity of Müllerian adenosarcoma, the gynecologists and pathologists should be reminded about the possibility of the diagnosis in young patients too.
Key words:  Müllerian adenosarcoma      Uterine      Mesenchymal tumor      Childhood      Vaginal bleeding      Adolescent     
Submitted:  10 September 2019      Accepted:  28 October 2019      Published:  15 October 2020     
*Corresponding Author(s):  TAJOSSADAT ALLAMEH     E-mail:  t_allameh@med.mui.ac.ir.

Cite this article: 

Tajossadat Allameh, Elham Naghshineh, Leila Mousavi Seresht, Parvin Rajabi, Narges Izadi-Mood. Uterine mullerian adenosarcoma in very young patient. European Journal of Gynaecological Oncology, 2020, 41(5): 817-820.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.05.5372     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I5/817

[1] Qunying Wu, Jin-Ho Kuk, Young-Joon Ryu. A Distinct Human Papilloma Virus Epidemiological Profile of Korean-Chinese Women Living in Yanbian, China[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 753-761.
[2] Jing Ma, Jiao Mu , Bin Lv , JiaYan Wu, Qing Gao, WeiSheng Huang, HongMei Dong. Sudden intrauterine fetal death due to a giant placental chorioangioma: a rare case report[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 838-840.
[3] Špela Smrkolj, Snježana Frković Grazio, Renata Košir Pogačnik. Endocervical adenocarcinoma in situ with ovarian metastasis: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 802-805.
[4] Michelle F. Benoit, Kristy K. Ward. Uterine Cancer Normogram to Predict Lymph Node Metastasis: Comparison to the Mayo Algorithm and an External Validation of a Model in a North American Population[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 681-684.
[5] Hyang Sook Jeong, Yuki Gen, Hui Ryun Joo, Ji Geun Yoo, Seung Geun Yeo, Dong Choon Park. Mesonephric-like carcinoma of the uterine corpus: A case report and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 664-667.
[6] Sun Yi Choe, Jung-Woo Park. Prognostic significance of the number of metastatic lymph nodes in early cervical cancer: a retrospective study[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 536-540.
[7] Chiharu Mizoguchi, Harunobu Matsumoto, Kaei Nasu, Kentaro Kai, Motoki Arakane, Hisashi Narahara. Collision tumour of endometrial stromal sarcoma, uterine tumour resembling ovarian sex-cord tumour, and leiomyoma[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 634-637.
[8] Tingting Cao, Naze Chen, Huaxin Sun, Rong Zhou, Jianliu Wang, Xiuju Yin. A rare case of primary extrauterine endometrial stromal sarcoma involving the sigmoid colon[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 661-663.
[9] Mustafa Ayhan Ekici, Ali Can Onal, Caglar Cetin. Likelihood of incidental finding of gynecological cancer in women undergoing hysterectomy for benign indications[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 402-407.
[10] Ming Wang, Shi-Hui Meng, Yu-Mei Wu. Ovarian conservation without postoperative radiation improved survival outcomes in patients with stage i uterine leiomyosarcoma[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 422-431.
[11] S. Liu, F. Ruan, M. Shi, Y. Liu, W. Li, B. Bi, H. Wang, W. Lv. Safe fertility-preserving management in a young woman with endometrial cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 476-479.
[12] S. H. Chung, J. H. Sang. Is there a difference between synchronous multiple primary cancer and metastasis cancer?[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 480-483.
[13] J. H. Sang, J. I. Choi, S.-H. Chung. Case series of uterine smooth muscle tumors of uncertain malignant potential (STUMP)[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 492-494.
[14] G. Raba, M. Wieliczko, E. KRASNIANIN. Uterine curettage prior to supracervical hysterectomy identifies a placental trophoblastic tumor – a case study[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 296-298.
[15] K. Sonoda, M. Nogami, K. Kodama, Y. Oda, K. Kato. Re-evaluation of preoperative endometrial smears for the cytodiagnosis of uterine leiomyosarcoma[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 167-170.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Akanksha Agrawal, Deepanshu Jain, Pradhum Ram, Jorge Luis Penalver Leon, Janani Rangaswami. Anticoagulation for intra-cardiac thrombi in peripartum cardiomyopathy: A review of the literature[J]. Reviews in Cardiovascular Medicine, 2019, 20(2): 53 -58 .
[3] B. Soltész, J. Lukács, A. Penyige, R. Póka, B. Nagy. Determination of miR-193b rs30236 single nucleotide polymorphism in ovarian cancer patients[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 547 -550 .
[4] Y. Li, C. Li, N. Li, L. Jiang, W. Yang, Y. Wang, B. Wu, C. Shi, Z. Zhu. RNAi silenced NUP88 gene suppresses growth and invasiveness of human breast cancer cell line MCF-7[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 634 -639 .
[5] M. Pakiž, L. Lukman, N. Kozar. Patients' and physicians' expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781 -786 .
[6] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879 -882 .
[7] Z. Protrka, P. Arsenijevic, N. Jovic, S. Zivanovic, J. Djuric, A. Dimitrijevic. A case of uterine torsion in term pregnancy associated with placental abruption and intrauterine fetal demise[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 287 -289 .
[8] T. Ueno, H. Yabushita, K. Iwasaki, A. Wakatsuki. Role of adiponectin and leptin in non-diabetic, non-obese patients with endometrial cancer[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 199 -204 .
[9] P. Pimsi, W. Santimaleeworagun, S. Therasakvichya, N. Saengsukkasemsak, A. Laocharoenkeat. The incidence and risk factors of severe neutropenia and febrile neutropenia due to chemotherapy among gynecologic cancer patients in Thailand[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 242 -246 .
[10] F. Lai-Tiong. Dermatomyositis revealing a 18-year breast cancer recurrence[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 292 -293 .